AffiAB® Goat anti-NSP16 (SARS-CoV-2) Polyclonal IgG Antibody provides highly specific recognition of NSP16 proteins to rapidly detect SARS-CoV-2. This antibody is capable of eliciting an efficient immune response and the results are reproducible and reliable.
The AffiAB® Goat anti-NSP16 (SARS-CoV-2) Polyclonal IgG Antibody is an antibody specifically designed to target and detect the NSP16 protein of the SARS-CoV-2 virus. NSP16, also known as 2'-O-methyltransferase, is a key enzyme involved in viral mRNA cap formation and viral replication.
This polyclonal antibody is produced by immunizing goats with purified NSP16 protein or a specific peptide sequence derived from NSP16. The resulting antibody is then purified from goat serum using various purification techniques to ensure high specificity and quality.
The AffiAB® Goat anti-NSP16 (SARS-CoV-2) Polyclonal IgG Antibody is widely used in research and diagnostic applications to study the SARS-CoV-2 virus. It can be utilized in techniques such as Western blotting, immunohistochemistry, immunofluorescence, and ELISA to detect and analyze the expression and localization of NSP16 in infected cells or patient samples.
By specifically targeting NSP16, this antibody enables researchers to investigate the function and role of the 2'-O-methyltransferase in the viral life cycle. Understanding NSP16 is crucial for elucidating the mechanisms of viral replication, mRNA capping, and pathogenesis of SARS-CoV-2.
In summary, the AffiAB® Goat anti-NSP16 (SARS-CoV-2) Polyclonal IgG Antibody is a valuable tool for scientists studying the SARS-CoV-2 virus and its key proteins. Its high specificity and sensitivity make it suitable for various research applications related to virology, immunology, and COVID-19 research.